Balchem Stock

Balchem Stocks 2024

Balchem Stocks

32.45 M

Ticker

BCPC

ISIN

US0576652004

WKN

905650

In 2024, Balchem had 32.45 M outstanding stocks, a 0% change from the 32.45 M stocks in the previous year.

The Balchem Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2026e32.45
2025e32.45
2024e32.45
202332.45
202232.4
202132.7
202032.5
201932.5
201832.4
201732.2
201631.9
201531.6
201431.2
201330.8
201230.4
201130.2
201029.6
200928.9
200828.5
200727.9
200627.4
200527.1
200426.2

Balchem shares outstanding

The number of shares was Balchem in 2023 — This indicates how many shares 32.448 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Balchem earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Balchem's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Balchem’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Balchem's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Balchem Aktienanalyse

What does Balchem do?

Balchem Corp is a US-based company specialized in the manufacture and sale of chemical additives and ingredients for a variety of industries. The company was founded in 1967 and is headquartered in New York. Balchem Corp offers a wide range of products and services, divided into different divisions. The largest divisions are Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. In the Human Nutrition & Health division, Balchem produces ingredients for use in functional foods, supplements, beverages, and other health products. The Animal Nutrition & Health division manufactures animal feed additives aimed at improving the health and growth of livestock. The Specialty Products division produces specialty chemicals for a variety of applications. Balchem Corp is also specialized in the development of fragrances and flavors. Balchem has become one of the leading manufacturers of amino acid derivatives, providing high-quality solutions for veterinary applications. Balchem Corp's history is characterized by expansion and diversification. In its early years, the company focused on the manufacture of chemical additives for the agriculture industry. One of Balchem's first achievements was the development of an additive that prevents feed from molding during transportation and storage. Over the years, Balchem has continuously expanded its offerings and now has a broad product portfolio serving many different industries. Balchem's expansion continued in the 1990s when the company started to expand its business into the human nutrition sector. Today, the Human Nutrition & Health division is the company's fastest-growing segment. Similar to the animal nutrition industry, Balchem also offers a variety of ingredients in this sector that have higher nutrient density and/or better bioavailability than conventional foods. In recent years, Balchem Corp has shown strong growth dynamics. In 2019, the company had a revenue of nearly $650 million. The company has been listed on NASDAQ since 1997 and has continuously increased its market value in recent years. Overall, Balchem Corp is an innovative and diversified company specialized in the manufacture of chemical additives and ingredients for various industries. The company has shown strong growth dynamics over the years and has continuously expanded its portfolio to meet the changing needs of its customers. With its broad product lines divided into different divisions, Balchem has solidified its position as a leading provider of additives and ingredients in many industries. Balchem Corp is a US-based company specialized in the manufacture and sale of chemical additives and ingredients for a variety of industries. Balchem ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Balchem's Shares Outstanding

Balchem's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Balchem’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Balchem’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Balchem’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Balchem stock

How many stocks are there of Balchem?

The current number of stocks of Balchem is 32.45 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Balchem are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Balchem evolved in recent years?

The number of shares of Balchem has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Balchem as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Balchem?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Balchem pay?

Over the past 12 months, Balchem paid a dividend of 0.79 USD . This corresponds to a dividend yield of about 0.44 %. For the coming 12 months, Balchem is expected to pay a dividend of 0.86 USD.

What is the dividend yield of Balchem?

The current dividend yield of Balchem is 0.44 %.

When does Balchem pay dividends?

Balchem pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Balchem?

Balchem paid dividends every year for the past 23 years.

What is the dividend of Balchem?

For the upcoming 12 months, dividends amounting to 0.86 USD are expected. This corresponds to a dividend yield of 0.48 %.

In which sector is Balchem located?

Balchem is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Balchem kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Balchem from 1/19/2024 amounting to 0.79 USD, you needed to have the stock in your portfolio before the ex-date on 12/26/2023.

When did Balchem pay the last dividend?

The last dividend was paid out on 1/19/2024.

What was the dividend of Balchem in the year 2023?

In the year 2023, Balchem distributed 0.71 USD as dividends.

In which currency does Balchem pay out the dividend?

The dividends of Balchem are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Balchem

Our stock analysis for Balchem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Balchem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.